FHI vs FSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

FHI

54.1
AI Score
VS
FHI Wins

FSK

39.3
AI Score

Investment Advisor Scores

FHI

54score
Recommendation
HOLD

FSK

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI FSK Winner
Forward P/E 11.534 6.2933 FSK
PEG Ratio 2.3532 3.2724 FHI
Revenue Growth 18.3% -24.0% FHI
Earnings Growth 19.3% 33.8% FSK
Tradestie Score 54.1/100 39.3/100 FHI
Profit Margin 21.3% -38.6% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL FHI

Relative Price Performance (Last 90 Days)

FHI 1M: +13.0% · 3M: +18.1% FSK 1M: +6.3% · 3M: -4.0%

Current Technical Phase

FHI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 70

RSI (14): 69.6 · Price: $63.94

FSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $11.09

Fundamentals Snapshot

Metric FHI FSK
Market Cap
Forward P/E 10.9 7.2
Trailing P/E 11.1
Revenue (TTM)
Revenue Growth 0.2% -0.2%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.7%
EPS 5.38 -1.96
Dividend Yield 0.02% 0.22%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.